Globus Medical is scheduled to report second-quarter 2026 results on August 6 after market close. The Zacks Consensus Estimate for revenues is $786.9 million, implying 5.6% growth from the prior year, while the consensus EPS estimate of $1.12 suggests a 30.3% increase. The company's Musculoskeletal Solutions segment is projected to grow 6.1% year over year, driven by strength in U.S. Spine, Trauma, and international markets, along with contributions from the Nevro acquisition. Enabling Technologies revenues are expected to rise 6.5% year over year, supported by adoption of the ExcelsiusGPS platform despite a shift toward leases and rentals. Globus Medical has an Earnings ESP of 0.00% and a Zacks Rank #3, indicating no clear signal for an earnings beat this quarter.
Globus MedicalExpected Q2 revenue and EPS growth, with consensus estimates showing increases.
